According to Arizton’s latest research report, the U.S. clinical laboratory tests market will grow at a CAGR of 2.17% from 2023 to 2029.
To Know More, Download the Free Sample Report: https://www.arizton.com/request-sample/4082
The U.S. Clinical Laboratory Tests Market Report Scope
|Market Size (2029)
|USD 109.09 Billion
|Market Size (2023)
|USD 95.89 Billion
|Test Complexity, Providers, and Test Type
Telemedicine and Direct-to-Consumer Solutions Creating New Market Opportunities
The COVID-19 pandemic has spurred significant transformations in the operations of clinical laboratories worldwide. One notable shift has been the increasing popularity of self-collection and at-home testing, with patients now expecting diagnostic testing to be accessible outside traditional settings such as hospitals and provider offices. This trend, highlighted in the Microlite Article 2023, is expected to continue growing in the US. Direct-to-consumer lab services, akin to over-the-counter pharmacy medications, allow patients to order diagnostic tests without a physician’s order, with results securely delivered directly to them by specialized labs.
Telemedicine has also seen widespread adoption for diagnosis and clinical lab services, with a staggering 97% of medical consultations transitioning to telemedicine during the pandemic. Hospitals, particularly in areas like New York, have implemented telemedicine systems to facilitate over 83,000 telemedicine visits and more than 30,000 consultations for healthcare diagnostics, including clinical diagnosis. This shift has led to a new dimension in healthcare, offering convenient and instant access to medical services for people globally.
Furthermore, the Community Health Center Report 2022 indicates that approximately 98% of community health centers in the US now utilize telemedicine/telehealth services to enhance diagnostic accessibility. These changes underscore a broader trend towards integrating technology into healthcare delivery, creating new revenue channels for clinical labs and offering patients greater autonomy and convenience in managing their health.
Most US clinical laboratory test companies offer routine or specialized clinical diagnostic testing services or both depending on their scientific expertise, technologies, innovations, and relevant regulations. Therefore, the competitive landscape in the country for the clinical laboratory tests market is highly localized and challenging. In certain areas, the competitive rivalry is mainly focused on branches and specialization of laboratories.
Currently, LabCorp and Quest Diagnostics operate as two significant independent laboratories across the US. These independent laboratories are domestic market players and hold a higher market share. Moreover, several international independent clinical laboratories are present across the country and compete with domestic small and mid-sized vendors. In the current landscape, high competition exists among LabCorp, Quest Diagnostics, Sonic Healthcare, and OPKO Health.
In 2023, the U.S. clinical laboratory tests market saw significant insights across different segments.
Insights by Test Complexity: Specialty tests emerged as the dominant segment, accounting for over 30% of lab tests. Though performed less frequently than routine tests, these tests play a crucial role in revenue growth due to their higher pricing. Government support and insurance coverage further accelerated growth in this segment, with genetics testing being a particularly lucrative area.
Insights by Providers: Hospital-based clinical laboratories claimed the largest market share. These facilities are integral to patient care, offering outpatient and inpatient diagnostic services. Integration with medical laboratories is a growing trend among hospitals, with Quest Diagnostics and LabCorp experiencing increased demand for integration, signaling revenue growth opportunities.
Insights by Test Type: Clinical and immunochemistry tests dominated the market, playing a key role in diagnosing health conditions and predicting future diseases. Specialty tests within this segment, such as enzymology, toxicology, and endocrinology, contributed to high revenue growth. Immunochemistry testing, which identifies antibodies and detects immune health issues, was particularly in demand, especially for organ transplantation procedures.
Overall, the U.S. clinical laboratory tests market witnessed dynamic shifts driven by advancements in specialty testing, the prominence of hospital-based laboratories, and the continued demand for clinical and immunochemistry tests.
The US Clinical Laboratory Tests Market Report Encompasses Crucial Data, Including:
CAGR (Compound Annual Growth Rate) during the forecast period: This metric provides insights into the annual growth rate of the US clinical laboratory tests market over the specified time frame.
Detailed information on growth drivers: The report offers in-depth information on the factors that will propel the US clinical laboratory tests market growth from 2023 to 2029. This includes an analysis of various market influences.
Precise estimation of market size: Accurate assessments of the US clinical laboratory tests market size and its contribution and focusing on key market segments.
Predictions about upcoming trends and changes in consumer behavior: The report offers insights into anticipated trends and shifts in consumer behavior that are likely to impact the US clinical laboratory tests market, helping businesses prepare for future market dynamics.
Geographical market growth: The report covers the clinical laboratory tests market development across the United States.
Competitive landscape analysis: A thorough examination of the market’s competitive landscape is presented, including detailed information about companies operating in the US clinical laboratory tests market. This includes an overview of key players, their market share, strategies, and key developments.
Analysis of growth challenges: The report includes a comprehensive analysis of factors that may pose challenges to the growth of companies in the US clinical laboratory tests market, providing a well-rounded view of the market dynamics.
- 1hr of free analyst discussion
- 10% off on customization
Key Company Profiles
- Eurofins Scientific
- Laboratory Corporation of America
- Mayo Clinic Laboratories
- OPKO Health, Inc. (BioReference Health)
- Quest Diagnostics
- Siemens Healthineers
- Sonic Healthcare
- Accu Reference Medical Labs
- ARUP Laboratories
- Clinical Reference Laboratory
- Empire City Laboratories
- Fresenius Medical Care
- Laboratory of Florida
- Millenium Health
- US Speciality Labs
- Specialty Tests
- Routine Tests
- Hospital-based Clinical Laboratory
- Independent Laboratories
- Physician Office Laboratories (PLOS)
- Clinical & Immunochemistry
- Molecular Diagnostics
- Microbiology & Cytology
Check Out the Detailed TOC @ https://www.arizton.com/market-reports/united-states-clinical-laboratory-test-market?details=tableOfContents
Key Questions Answered in the Report:
How big is the U.S. clinical laboratory tests market?
What is the growth rate of the U.S. clinical laboratory tests market?
Which provider segment dominates the U.S. clinical laboratory tests market share?
What are the significant trends in the U.S. clinical laboratory tests market?
Who are the key players in the U.S. clinical laboratory tests market?
Check Out Some of the Top-Selling Research Reports:
Arizton’s Expertise in the Healthcare Industry
Arizton offers syndicate and custom market intelligence & competitive intelligence solutions across MedTech, pharmaceuticals, and life sciences & biotechnology markets within the healthcare industry. Arizton’s healthcare vertical provides unbiased research and evidence-based analysis to support business decisions and comprehensive end-to-end solutions to its customers, covering all dimensions of the healthcare value chain. We track various devices (equipment, implants, and hospital supplies) and drugs (patented, generic, & OTC) across North America, Europe, APAC, Latin America, and the Middle East & Africa regions. The healthcare reports provide historic and forecast data for 20+ key countries worldwide. We track product approvals/launches, M&A activities, and collaboration/partnership activities among pharma/biotech, medical device, and life sciences companies. Our pharmaceutical portfolio tracks 15+ therapy areas with a major focus on immunology, oncology, rare & genetic diseases, dermatology, and metabolic diseases. Our medical devices and life sciences portfolio covers in-vitro diagnostics, healthcare IT, patient monitoring, cardiovascular devices, medical imaging, personal protective equipment, clinical laboratory services, and CMO/CDMO services.
100% Customer Satisfaction
24×7 availability – we are always there when you need us
200+ Fortune 500 Companies trust Arizton’s report
80% of our reports are exclusive and first in the industry
100% more data and analysis
1500+ reports published till date
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.